Zdrowie i gospodarka · 14/08/2014
FDA Releases Revised Draft Guidance on Clinical Pharmacology Labeling for Human Prescription Drugs
The FDA has made available a revised draft guidance for industry on the content and format of labeling for human prescription drugs and biological products, aiming to assist applicants in complying with FDA regulations.
Source: Federal Register — Food and Drug AdministrationOpen original release →